Lilly strengthens gene therapy portfolio with MeiraGTx and Adverum deals
Eli Lilly Expands Gene Therapy Pipeline Through Strategic Acquisitions The race to dominate the next frontier of medicine is intensifying, and pharmaceutical giant Eli Lilly is making a powerful statement. In a strategic move to solidify its position in the burgeoning field of genetic medicine, Lilly has significantly expanded its gene therapy portfolio through two […]
Lilly strengthens gene therapy portfolio with MeiraGTx and Adverum deals Read More »
